Exicure (XCUR) Assets (2016 - 2026)
Exicure's (XCUR) quarterly Assets came in at $12.8 million in Q1 2026, down 38.32% YoY from $20.7 million in Q1 2025, and down 9.16% on a QoQ basis from $14.0 million in Q4 2025.
Exicure (XCUR) Assets (2016 - 2026) Analysis & Trends
Exicure (XCUR) has 11 years of Assets data on file, last reported at $12.8 million in Q1 2026.
- Quarterly Assets fell 38.32% year-over-year to $12.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.8 million (down 38.32% YoY) and the FY2025 annual result came in at $14.0 million, down 6.74% from the prior year.
- Assets slipped to $12.8 million in Q1 2026, from $14.0 million in the prior quarter.
- In the past five years, Assets ranged from a high of $41.9 million in Q1 2022 to a low of $10.6 million in Q3 2024.
- A 5-year average of $19.2 million and a median of $15.3 million in 2025 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets slumped 64.04% — and 2025, when it surged 93.07%.
- Tracing XCUR's Assets over 5 years: stood at $23.3 million in 2022, then sank by 50.36% to $11.6 million in 2023, then jumped by 30.02% to $15.1 million in 2024, then decreased by 6.74% to $14.0 million in 2025, then declined by 9.16% to $12.8 million in 2026.
- The last three Assets figures came in at $12.8 million (Q1 2026), $14.0 million (Q4 2025), and $15.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Exicure | 8.41 Mn | 8.41 Mn | - | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.76 Mn |
| Dec 31, 2025 | 14.04 Mn |
| Sep 30, 2025 | 15.27 Mn |
| Jun 30, 2025 | 18.74 Mn |
| Mar 31, 2025 | 20.68 Mn |
| Dec 31, 2024 | 15.06 Mn |
| Sep 30, 2024 | 10.63 Mn |
| Jun 30, 2024 | 10.69 Mn |
| Mar 31, 2024 | 10.71 Mn |
| Dec 31, 2023 | 11.58 Mn |
| Sep 30, 2023 | 12.95 Mn |
| Jun 30, 2023 | 17.56 Mn |
| Mar 31, 2023 | 23.94 Mn |
| Dec 31, 2022 | 23.33 Mn |
| Sep 30, 2022 | 28.94 Mn |
| Jun 30, 2022 | 36.96 Mn |
| Mar 31, 2022 | 41.90 Mn |
| Dec 31, 2021 | 64.87 Mn |
| Sep 30, 2021 | 77.90 Mn |
| Jun 30, 2021 | 74.47 Mn |